ALK-negative anaplastic large cell lymphoma, leukemic phase
Shoot for 150-160 chars
Shoot for 150-160 chars
Background Multiple myeloma (MM) is a major health concern. Understanding the different burden and tendency of MM in different regions is crucial for formulating specific…
Limitations in the ASC4FIRST trial : Asciminib in Newly Diagnosed Chronic Myeloid Leukemia.
Yiwang Zhou St. Jude Children’s Research Hospital, Memphis, TN Yiwang Zhou, Madeline Horan, Jaesung Choi, Rachel T Webster, Tara M. Brinkman, Daniel A. Mulrooney, Deo…
Speaking of Illusions: Sirtuins and Longevity
Cancer is an international interdisciplinary journal publishing articles on the latest clinical cancer research findings, spanning the breadth of oncology disciplines.
The Lancet Commission on Women, Power, and Cancer was created to address the overlapping forms of discrimination that women face in cancer prevention and treatment…
Trastuzumab deruxtecan showed anti-tumour activity and durable responses in heavily pretreated patients across multiple tumour types with activating HER2 mutations, with no new safety signals.…
In men with prostate-specific membrane antigen–defined, oligorecurrent M1a–b prostate cancer, short-course androgen annihilation therapy and metastasis-directed stereotactic body radiotherapy achieved a substantial disease-free interval following…
According to the National Cancer Institute, an individual is considered a cancer survivor from the time of diagnosis, through the balance of his or her…
On my first day as an attending physician in a new hospital, I found my house staff and students in the team room, a snug…